Capricor Therapeutics Inc

CAPRNASDAQ · USD
9.06USD0.00 (-3.83%)
1210

Capricor Therapeutics Inc (CAPR) Historical Volatility

CAPR 30-day historical volatility is 175%. This ranks in the 74th percentile of readings over the past year.

Read more

Tracking CAPR historical volatility helps you see how much Capricor Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Capricor Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor CAPR 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The CAPR 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Capricor Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19.

It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Capricor Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where CAPR HV is running hot, cold, or in line. Make the CAPR 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 17, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 17, 2026

See how volatility has moved over time

Track CAPR historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial